{
  "compound": "THC+CBD oil (THC 10 mg/mL + CBD 15 mg/mL)",
  "condition": "TOURETTE_SYNDROME",
  "effect_size": "Pilot feasibility",
  "study_type": "RCT",
  "source": "NORML:TS_RCT_009",
  "participants": "10 adolescents randomized; 7 completed",
  "year": 2025,
  "notes": "A Pilot Randomized Placebo-Controlled Crossover Trial of Medicinal Cannabis in Adolescents with Tourette Syndrome",
  "confidence": "medium",
  "abstract": "Feasible protocol with high visit/blood-test completion; CGI-I: 3 rated much improved on active vs 1 on placebo at 10 weeks; efficacy not powered"
}